$129.46
+0.18 (+0.14%)
Last updated: Apr 16, 2026 02:32
Fundamentals Overview
Blueprint Medicines Corporation is in the middle of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Risk (Beta)
0.83 — in line vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Pressures (Sell):
Sentiment weakening (7 downgrades)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Recent institutional grades: majority downgrades. Current institutional positions: Buy: 10, Equal Weight: 2, Hold: 1, Market Outperform: 5, Market Perform: 1, Neutral: 5, Outperform: 2, Overweight: 2, Peer Perform: 1, Sector Perform: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-167.10; current price is $129.46. That’s a -229.1% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| PEG (TTM) | N/A |
| P/B (TTM) | 24.07 |
| P/S (TTM) | 28.27 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.8 |
| Quick Ratio (TTM) | 2.75 |
| Cash Ratio (TTM) | 0.49 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -16.72% |
| Gross margin (TTM) | 96.53% |
| Operating margin (TTM) | -27.82% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for BPMC.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Wells Fargo | downgrade | Overweight | Equal Weight | 2025-06-17 |
| UBS | maintain | Neutral | Neutral | 2025-06-05 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-06-05 |
| Citigroup | upgrade | Sell | Neutral | 2025-06-04 |
| JMP Securities | downgrade | Market Outperform | Market Perform | 2025-06-03 |
| Wolfe Research | downgrade | Outperform | Peer Perform | 2025-06-03 |
| Wedbush | downgrade | Outperform | Neutral | 2025-06-02 |
| Needham | downgrade | Buy | Hold | 2025-06-02 |
| Scotiabank | downgrade | Sector Outperform | Sector Perform | 2025-06-02 |
| JP Morgan | downgrade | Overweight | Neutral | 2025-06-02 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-05-02 |
| Needham | maintain | Buy | Buy | 2025-04-28 |
| Wedbush | maintain | Outperform | Outperform | 2025-04-16 |
| Needham | maintain | Buy | Buy | 2025-04-08 |
| Citizens Capital Markets | maintain | Market Outperform | Market Outperform | 2025-03-03 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2025-02-14 |
| JMP Securities | maintain | Market Outperform | Market Outperform | 2025-02-14 |
| Needham | maintain | Buy | Buy | 2025-02-14 |
| Needham | maintain | Buy | Buy | 2025-02-13 |
| JP Morgan | maintain | Overweight | Overweight | 2025-02-04 |
| Piper Sandler | maintain | Neutral | Neutral | 2025-01-27 |
| JMP Securities | maintain | Market Outperform | Market Outperform | 2025-01-15 |
| Needham | maintain | Buy | Buy | 2025-01-13 |
| Wedbush | maintain | Outperform | Outperform | 2025-01-13 |
| Stephens & Co. | maintain | Overweight | Overweight | 2025-01-02 |
| Needham | maintain | Buy | Buy | 2024-12-17 |
| Guggenheim | maintain | Buy | Buy | 2024-12-11 |
| JMP Securities | maintain | Market Outperform | Market Outperform | 2024-12-09 |
| JMP Securities | maintain | Market Outperform | Market Outperform | 2024-11-18 |
| Needham | maintain | Buy | Buy | 2024-11-15 |